摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

methyl 1-(3-chloropyridin-2-yl)-3-pyrazolidinone-5-carboxylate | 774600-50-9

中文名称
——
中文别名
——
英文名称
methyl 1-(3-chloropyridin-2-yl)-3-pyrazolidinone-5-carboxylate
英文别名
methyl 2-(3-chloro-2-pyridinyl)-5-oxo-3-pyrazolidinecarboxylate;methyl 2-(3-chloropyridin-2-yl)-5-oxopyrazolidine-3-carboxylate
methyl 1-(3-chloropyridin-2-yl)-3-pyrazolidinone-5-carboxylate化学式
CAS
774600-50-9
化学式
C10H10ClN3O3
mdl
——
分子量
255.661
InChiKey
SHEDCLCLCJLNPZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 密度:
    1.426±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.1
  • 重原子数:
    17
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.3
  • 拓扑面积:
    71.5
  • 氢给体数:
    1
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    methyl 1-(3-chloropyridin-2-yl)-3-pyrazolidinone-5-carboxylate三溴氧磷 作用下, 以 乙腈 为溶剂, 反应 0.02h, 以86%的产率得到3-bromo-1-(3-chloro-2-pyridyl)-4,5-dihydro-1H-pyrazole-5-carboxylic acid methyl ester
    参考文献:
    名称:
    一种微通道工业化生产溴代吡唑烷酸的方法
    摘要:
    本发明涉及一种微通道工业化生产溴代吡唑烷酸的方法,以2‑卤代杂环类化合物为原料,在微通道反应器中进行肼解、关环、溴代和水解反应,酸化、过滤后得到高收率和高纯度的溴代吡唑烷酸,大幅缩短了反应时间,安全性高、污染小、污染物排放少,成本低、后处理简单,每一步中间产物的收率80%以上,纯度90%以上,最终产品纯度95%以上,特别适合工业化大规模生产。
    公开号:
    CN111440144A
  • 作为产物:
    描述:
    2-肼基-3-氯吡啶氯化亚砜 、 nickel(II) dichloro tris(triphenylphoshpine) 、 sodium methylate 作用下, 以 甲醇甲苯 为溶剂, 反应 15.0h, 生成 methyl 1-(3-chloropyridin-2-yl)-3-pyrazolidinone-5-carboxylate
    参考文献:
    名称:
    一种吡啶基吡唑烷酮羧酸酯类化合物的合成 方法
    摘要:
    本发明属于有机合成领域,具体地涉及一种吡啶基吡唑烷酮羧酸酯类化合物的制备方法。本发明提供了一种吡啶基吡唑烷酮羧酸酯类化合物的合成新方法,该方法以肼基吡啶与马来酸酐为原料,经取代、酯化、环合反应三步制备得到吡啶基吡唑烷酮羧酸酯类化合物,反应收率高,选择性好。与已报道方法相比,该方法所用原料简单、易得,反应条件温和,收率高,污染小,合成的产品纯度高,易于工业化生产。
    公开号:
    CN106831705B
点击查看最新优质反应信息

文献信息

  • [EN] PREPARATION AND USE OF 2-SUBSTITUTED-5-OXO-3- PYRAZOLIDINECARBOXYLATES<br/>[FR] PREPARATION ET UTILISATION DE PYRAZOLIDINECARBOXYLATES-5-OXO-3-SUBSTITUES-2
    申请人:DU PONT
    公开号:WO2004087689A1
    公开(公告)日:2004-10-14
    A method is disclosed for preparing a 2-substituted-5-oxo-3-pyrazolidinecarboxylate compound of Formula I. The method comprises contacting a succinic acid derivative of the formula R1OC(O)C(H)(X)C(R2a)(R2b)C(O)Y (i.e. Formula II) wherein X and Y are leaving groups and L, R1, R2a and R2bare as defined in the disclosure, with a substituted hydrazine of the formula LNHNH2 (i.e. Formula III) in the presence of a suitable acid scavenger and solvent. Also disclosed is the preparation of compounds of Formula IV wherein X1, R6, R7, R8a, R8b, R9, and n are as defined in the disclosure. Also disclosed is a composition comprising on a weight basis about 20 to 99% of the compound of Formula II wherein R1, R2a, R2b, R3, R4 and R5 are as defined in the disclosure; X is Cl, Br or I; and Y is F, Cl, Br or I; provided that when R2a and R2b are each H, and X and Y are each Cl then R1 is other than benzyl and when R2a and R2b are each phenyl, and X and Y are each Cl, then R1 is other than methyl or ethyl. Also disclosed is a crystalline composition comprising at least about 90% by weight of the compound of the formula R1OC(O)C(H)(X)C(R2a)(R2b)CO2H (i.e. Formula VI) wherein R2a and R2b are H, X is Br and R1 is methyl.
    揭示了一种制备化合物的方法,该化合物为公式I中的2-取代-5-氧代-3-吡唑烷羧酸酯。该方法包括将公式为R1OC(O)C(H)(X)C(R2a)(R2b)C(O)Y(即公式II)的琥珀酸衍生物与适当的酸中和剂和溶剂存在下,与公式为LNHNH2(即公式III)的取代肼接触。还揭示了制备公式IV中的化合物,其中X1、R6、R7、R8a、R8b、R9和n如披露中所定义。还揭示了一种组合物,按重量基准含有约20至99%的公式II中的化合物,其中R1、R2a、R2b、R3、R4和R5如披露中所定义;X为Cl、Br或I;Y为F、Cl、Br或I;但当R2a和R2b分别为H,X和Y分别为Cl时,则R1不是苄基;当R2a和R2b分别为苯基,X和Y分别为Cl时,则R1不是甲基或乙基。还揭示了一种晶体组合物,其至少按重量含有约90%的公式为R1OC(O)C(H)(X)C(R2a)(R2b)CO2H(即公式VI)的化合物,其中R2a和R2b为H,X为Br,R1为甲基。
  • PREPARATION AND USE OF 2-SUBSTITUTED-5-OXO-3-PYRAZOLIDINECARBOXYLATES
    申请人:ANNIS GARY DAVID
    公开号:US20090036686A1
    公开(公告)日:2009-02-05
    A method is disclosed for preparing a 2-substituted-5-oxo-3-pyrazolidinecarboxylate compound of Formula I The method comprises contacting a succinic acid derivative of the formula R 1 OC(O)C(H)(X)C(R 2a )(R 2b )C(O)Y (i.e. Formula II) wherein X and Y are leaving groups and L, R 1 , R 2a and R 2b are as defined in the disclosure, with a substituted hydrazine of the formula LNHNH 2 (i.e. Formula III) in the presence of a suitable acid scavenger and solvent. Also disclosed is the preparation of compounds of Formula IV wherein X 1 , R 6 , R 7 , R 8a , R 8b , R 9 , and n are as defined in the disclosure. Also disclosed is a composition comprising on a weight basis about 20 to 99% of the compound of Formula II wherein R 1 , R 2a , R 2b , R 3 , R 4 and R 5 are as defined in the disclosure; X is Cl, Br or I; and Y is F, Cl, Br or I; provided that when R 2a and R 2b are each H, and X and Y are each Cl then R 1 is other than benzyl and when R 2a and R 2b are each phenyl, and X and Y are each Cl, then R 1 is other than methyl or ethyl. Also disclosed is a crystalline composition comprising at least about 90% by weight of the compound of the formula R 1 OC(O)C(H)(X)C(R 2a )(R 2b )CO 2 H (i.e. Formula VI) wherein R 2a and R 2b are H, X is Br and R 1 is methyl.
    本发明公开了一种制备式I的2-取代-5-氧代-3-吡唑烷羧酸酯化合物的方法,该方法包括将式II的琥珀酸衍生物与一种取代的式III的肼在合适的酸清除剂和溶剂的存在下接触。其中,X和Y是离去基团,L、R1、R2a和R2b如本文所定义。本发明还公开了制备式IV化合物的方法,其中X1、R6、R7、R8a、R8b、R9和n如本文所定义。本发明还公开了一种组合物,其包括按重量计约20至99%的式II化合物,其中R1、R2a、R2b、R3、R4和R5如本文所定义;X为Cl、Br或I;Y为F、Cl、Br或I;但当R2a和R2b都为H,且X和Y都为Cl时,R1不是苄基;当R2a和R2b都为苯基,且X和Y都为Cl时,R1不是甲基或乙基。本发明还公开了一种晶体组合物,其包括至少按重量计约90%的式VI的化合物,其中R2a和R2b为H,X为Br,R1为甲基。
  • Preparation and use of 2-substituted-5-oxo-3-pyrazolidinecarboxylates
    申请人:Annis David Gary
    公开号:US20070021468A1
    公开(公告)日:2007-01-25
    A method is disclosed for preparing a 2-substituted-5-oxo-3-pyrazolidinecarboxylate compound of Formula I. The method comprises contacting a succinic acid derivative of the formula R 1 OC(O)C(H)(X)C(R 2a )(R 2b )C(O)Y (i.e. Formula II) wherein X and Y are leaving groups and L, R 1 , R 2a and R 2b are as defined in the disclosure, with a substituted hydrazine of the formula LNHNH 2 (i.e. Formula III) in the presence of a suitable acid scavenger and solvent. Also disclosed is the preparation of compounds of Formula IV wherein X 1 , R 6 , R 7 , R 8a , R 8b , R 9 , and n are as defined in the disclosure. Also disclosed is a composition comprising on a weight basis about 20 to 99% of the compound of Formula II wherein R 1 , R 2a , R 2b , R 3 , R 4 and R 5 are as defined in the disclosure; X is Cl, Br or I; and Y is F, Cl, Br or I; provided that when R 2a and R 2b are each H, and X and Y are each Cl then R 1 is other than benzyl and when R 2a and R 2b are each phenyl, and X and Y are each Cl, then R 1 is other than methyl or ethyl. Also disclosed is a crystalline composition comprising at least about 90% by weight of the compound of the formula R 1 OC(O)C(H)(X)C(R 2a )(R 2b )CO 2 H (i.e. Formula VI) wherein R 2a and R 2b are H, X is Br and R 1 is methyl.
    公开了制备式I的2-取代-5-氧代-3-吡唑啉羧酸酯化合物的方法。该方法包括在适当的酸清除剂和溶剂存在下,将式II的琥珀酸衍生物与式III的取代肼接触,其中X和Y是离去基团,L、R1、R2a和R2b如披露中所定义。还公开了制备式IV的化合物的方法,其中X1、R6、R7、R8a、R8b、R9和n如披露中所定义。还公开了一种组合物,其按重量基础包括约20至99%的式II的化合物,其中R1、R2a、R2b、R3、R4和R5如披露中所定义;X为Cl、Br或I;Y为F、Cl、Br或I;但当R2a和R2b均为H且X和Y均为Cl时,R1不为苄基,当R2a和R2b均为苯基且X和Y均为Cl时,R1不为甲基或乙基。还公开了一种晶体组合物,其至少包括按重量90%的式VI的化合物,其中R2a和R2b为H,X为Br,R1为甲基。
  • Hydrazide compounds as intermediates of pesticides
    申请人:Sumitomo Chemical Company, Limited
    公开号:EP2251336A1
    公开(公告)日:2010-11-17
    The compounds represented by the formulae (2-i) and (II) are intermediates for the preparation of pesticides.
    式(2-i)和(II)所代表的化合物 是制备杀虫剂的中间体。
  • PREPARATION AND USE OF 2-SUBSTITUTED-5-OXO-3- PYRAZOLIDINECARBOXYLATES
    申请人:E.I. DUPONT DE NEMOURS AND COMPANY
    公开号:EP1606276A1
    公开(公告)日:2005-12-21
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物